Results with newer bladeless LASIK equivalent to standard microkeratome LASIK
A Mayo Clinic study comparing femtosecond (bladeless) and mechanical microkeratome LASIK surgeries has found equal results from both types six months post-surgery, using a variety of vision and eye health measurements. The study's findings will be presented next week in three abstracts at the Association for Research in Vision and Ophthalmology meeting in Fort Lauderdale, Fla. LASIK (Lase...
equivalent at Biology Products
equivalent at Biology Technology
equivalent at Medicine News
Oral Cancer: Awareness is Not Equivalent To Knowledge
New research appearing in the latest edition of the British Dental Journal says that although the public awareness of oral cancer is good, the knowledge of the early signs and symptoms of the same is way below expectations. // Reserachers at University College, London and Guy's, King's and St Thomas' Dental Institute found that 95 percent of those surveyed had heard of oral cancer or m...
Exposure to CT Scan Radiation may Be Equivalent to That of Nuclear Bomb
Experts at the American College of Radiologists have warned doctors against exposing patients to CT scans unnecessarily because the use of X-ray technology increases the risk of cancer. They suggest that the amount of radiation that patients are exposed to during CT scans may in some cases be
equivalent to that received by some survivors of the Hiroshima and Nagasaki atomic bombs....
equivalent at Medicine Products
equivalent at Medicine Technology
Data Presented at AACR Meeting Show Peregrine's Bavituximab
Equivalent Can Generate Curative Immune Responses as Part of a
Vaccine-Like Regimen in Preclinical Models of Aggressive Brain
Cancer
--Immunization with a Bavituximab
Equivalent and Irradiated TumorCells Increased Long-Term Survival to 57% From 0% in Controls in aPreclinical Model of Brain Cancer-- LOS ANGELES and TUSTIN, Calif., April 18, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of cancer and hep...
Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus
Docetaxel Reduces Growth of Both Hormone-Dependent and
Hormone-Independent Prostate Cancer by Up to 94 Percent in
Preclinical Studies
- Combination Therapy Significantly Decreased Tumor Blood VesselDensity and Serum PSA Levels in Prostate Tumors - LOS ANGELES and TUSTIN, Calif., April 17, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of cancer and hepatitis Cvirus (HCV) infection, today announced that p...
Study: Identical Doses of BiDil Components Are Not Bioequivalent to
the Fixed Dose Combination-BiDil-Used in A-HeFT
NEW ORLEANS, La.--(BUSINESS WIRE)--Mar 26, 2007 - A study comparingthe formulations of isosorbide dinitrate (ISDN) and hydralazine(HYD) used in V-HeFT I and V-HeFT II, and BiDil, the proprietaryfixed dose combination, used in the African American Heart FailureTrial (A-HeFT) demonstrated no bioequivalence. Non-bioequivalencein the formulations used may explain why V-HeFT I and V-HeFT IIshowe...